Vol. 6, Issue 1, Part A (2024)

Background: Primary liver cancer, particularly hepatocellular carcinoma (HCC), is a significant global health issue. Racial and ethnic disparities in the incidence, treatment, and outcomes of primary liver cancer have been well documented, yet the underlying causes and consequences of these disparities are complex and multifactorial. Understanding these factors is essential for developing targeted interventions to reduce disparities and improve health equity.
Objective: This paper aims to explore the causes and consequences of racial and ethnic disparities in primary liver cancer, with a focus on incidence, access to care, treatment outcomes, and survival rates.
Methods: A comprehensive literature review was conducted, focusing on studies published between 2000 and 2023. Data were analyzed to identify patterns of disparities among different racial and ethnic groups, including African Americans, Hispanics, Asian Americans, and non-Hispanic Whites. Statistical analysis was used to compare incidence rates, treatment access, and survival outcomes across these groups.
Results: The analysis revealed significant disparities in the incidence and outcomes of primary liver cancer among different racial and ethnic groups. African Americans and Hispanics were found to have higher incidence rates and worse survival outcomes compared to non-Hispanic Whites. Asian Americans, despite having higher incidence rates, often exhibited better survival outcomes due to earlier detection and better access to culturally tailored care. Factors contributing to these disparities include socioeconomic status, access to healthcare, cultural beliefs, and biological differences.
Conclusion: Racial and ethnic disparities in primary liver cancer are driven by a complex interplay of social, economic, and biological factors. Addressing these disparities requires a multifaceted approach that includes improving access to care, increasing awareness and screening in high-risk populations, and developing culturally sensitive interventions. Efforts to reduce these disparities will be essential in improving overall outcomes for primary liver cancer patients.